Diuretic Renography: Lasix Washout & Obstruction

Diuretic renography answers one deceptively hard question: is a dilated collecting system actually obstructed, or just baggy? Anatomic imaging — ultrasound, CT, MRI — readily shows a dilated renal pelvis or ureter, but dilation does not equal obstruction. By stimulating a high rate of urine flow with furosemide (Lasix) and watching how fast a renal radiopharmaceutical washes out, diuretic renography separates a system that drains freely under stress from one that stays trapped.¹²

The study is noninvasive, widely available, and evaluates both differential renal function and urine transit in a single acquisition. But its accuracy depends entirely on technique: adequate hydration, a standardized furosemide-timing protocol, bladder management, clean regions of interest, and a correctly computed washout half-time. Get those right and the result is trustworthy; get them wrong and the scan produces false positives that can send a patient toward unnecessary intervention.¹²

Introduction

The core problem is that urinary tract dilation is common and usually does not need surgery. A dilated collecting system can result from a prior obstruction that has resolved, high flow, reflux, a capacious but functionally normal pelvis, or a partial obstruction that genuinely threatens the kidney. Distinguishing the last category — true, functionally significant obstruction — is what protects renal function while sparing patients from operating on dilation that would have been fine left alone.¹²

Diuretic renography addresses this by converting a static anatomic finding into a functional test. The kidney is imaged dynamically after injection of a Tc-99m-labeled renal radiopharmaceutical, and furosemide is administered to drive urine flow to a high rate. In a non-obstructed system, the surge of urine flushes tracer out of the collecting system quickly. In a truly obstructed system, the tracer remains trapped despite maximal diuresis. The rate of washout — quantified as a half-time — is the headline number.¹³

This guide walks through the radiopharmaceuticals, the furosemide-timing protocols, the physics of the washout half-time, the pitfalls that create false positives, the quality-control and regulatory context, and how a medical physics program keeps the quantitation defensible. The framework follows the SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults, supported by the nuclear-nephrology literature.¹²

Topic Explanation

What diuretic renography measures

Diuretic renography measures two things at once: how well each kidney functions relative to the other, and how quickly urine — and the tracer dissolved in it — transits out of the collecting system under a diuretic stress. The dynamic acquisition produces a time-activity curve (the renogram) for each kidney, typically showing an uptake phase as tracer is extracted from blood, a peak, and an excretory phase as tracer drains. Superimposing a controlled diuresis on the excretory phase is what reveals whether drainage is flow-limited (clears promptly) or truly obstructed (does not clear).¹² The uptake-phase measurement of relative function, and the clearance methods behind it, are standardized in the nuclear-nephrology literature.⁷⁸

Key terms used throughout:

• Renogram — the time-activity curve of tracer in a kidney region of interest.
• Differential (relative) function — the percentage split of function between the two kidneys, usually taken from the uptake phase.
• Washout half-time ($T_{1/2}$) — the time for activity in the collecting-system region to fall to half its value after the diuretic takes effect.
• Furosemide-timing protocol — the convention naming when furosemide is given relative to tracer injection (for example, F + 20 means 20 minutes after tracer).

Why furosemide is the engine of the test

Furosemide is a loop diuretic that rapidly increases urine flow. In adults with normal renal function, a 40 mg dose produces maximal diuresis, with urine flow rates reaching roughly 20 mL/min within about 3 to 6 minutes.¹ That surge is the physiologic "stress test" for the collecting system. The logic is simple: a wide but healthy pelvis will empty when urine pours through it, whereas a genuine obstruction will hold onto the tracer no matter how hard the kidney is pushed to make urine. The response to the diuretic — not the baseline appearance — is diagnostic.¹³

Where this fits with other renal studies

Diuretic renography is complementary to the broader renal-scintigraphy toolkit. For the differential-function and GFR side of nuclear nephrology, see our guide to renal scintigraphy and split renal function. The quantitative discipline that underlies both — calibration, region-of-interest hygiene, and reproducible processing — is the same one covered in quantitative SPECT/CT calibration.

Key Technical Principles

Choosing the radiopharmaceutical

The agent determines image quality, especially when function is impaired. Tc-99m MAG3 (mercaptoacetyltriglycine) is cleared primarily by tubular secretion with high extraction, so it delivers strong target-to-background images even in reduced function — making it the workhorse for diuretic renography. Tc-99m DTPA is cleared by glomerular filtration and is a reasonable choice when function is good. Tc-99m ethylenedicysteine (EC) is a tubular agent with clearance slightly higher than MAG3.¹

A typical adult administered activity is in the range of about 37 to 185 MBq (1 to 5 mCi), with activities up to roughly 370 MBq (10 mCi) used when a high-quality first-pass bolus (radionuclide angiogram) is required to assess perfusion. Using the lowest activity that yields adequate counts keeps patient dose as low as reasonably achievable.¹

The furosemide-timing protocols

The protocols are named by when furosemide is injected relative to the tracer:¹

• F + 20 — furosemide 20 minutes after tracer. The Santa Fe Consensus recommended a 35-minute acquisition with furosemide given 20 minutes in; a single acquisition can be split into a baseline phase and a post-furosemide phase.
• F − 15 — furosemide 15 minutes before tracer, so the collecting system is already under maximal diuresis when the tracer arrives; useful for shortening the study and for markedly dilated systems.
• F = 0 — furosemide at the same time as tracer.
• F + 2, F + 5, F + 10, F + 30, and Fmax — variants giving furosemide at other fixed times or at the point of maximal collecting-system filling.

The standard adult furosemide dose is 0.5 mg/kg or 40 mg; in practice a 20 to 30 mg dose usually produces adequate diuresis in normal kidneys, and the choice of protocol is matched to the clinical question and the degree of dilation.¹

Computing the washout half-time

The washout half-time is derived from the descending (post-diuretic) portion of the renogram, modeled as a monoexponential clearance. If the collecting-system activity falls from $A_1$ at time $t_1$ to $A_2$ at time $t_2$, the clearance rate constant $k$ is:

and the washout half-time is:

Worked example. Suppose furosemide is given at F + 20 and the collecting-system region contains 10,000 counts at the moment of peak filling and 4,000 counts 10 minutes later. Then:

A washout half-time of about 7.6 minutes is under the roughly 10-minute threshold and therefore excludes obstruction. Interpretation generally follows these bands, with the strong caveat that the thresholds are not perfectly standardized and must be read alongside the curve shape and the degree of function:¹²

• $T_{1/2}$ under about 10 minutes — prompt washout; excludes obstruction.
• $T_{1/2}$ about 10 to 20 minutes — equivocal/indeterminate.
• $T_{1/2}$ over about 20 minutes — consistent with obstruction.

Crucially, a dilated system with poor function may wash out slowly simply because it cannot generate a brisk diuresis — a half-time computed on a kidney that never responded to furosemide is not evidence of mechanical obstruction. This is why the half-time is interpreted as one element of a complete study, not as a stand-alone verdict.²

Clinical Impact

The purpose of the test is to protect kidneys from unnecessary surgery and from missed obstruction alike. A false-positive study — slow apparent washout that is really dehydration or poor function — can push a patient toward a pyeloplasty or stent they did not need. A false-negative — calling a borderline system "non-obstructed" when it is slowly failing — can let a kidney deteriorate. Because the stakes are a surgical decision and long-term renal function, the quality of the quantitation is not a technical nicety; it is the clinical product.¹²

Diuretic renography is also used serially. After an intervention, or to follow a dilated but functionally stable kidney, repeat studies track whether washout and differential function are improving, stable, or declining. Serial comparison only works if the technique is reproducible from study to study — the same agent, the same protocol, the same hydration state, and consistent processing — which again puts the burden on standardized technique and quality control.²

Practical Optimization Tips

Standardize hydration and the bladder

Most false positives trace back to physiology outside the kidney. The patient should arrive well hydrated and receive an additional oral fluid load — on the order of 5 to 10 mL/kg of body weight 30 to 60 minutes before the study — or clinically indicated intravenous hydration.¹ A full bladder raises back-pressure and slows upper-tract drainage, so bladder management (voiding, or a catheter in selected patients) is part of the protocol. A post-void image is valuable when obstruction is suspected.¹

Protect the quantitation

• Region-of-interest discipline. For F + 20, F + 30, Fmax, and the furosemide portion of dual-acquisition protocols, a half-time calculated from an ROI limited to the dilated pelvis or collecting system is more meaningful than a whole-kidney ROI, because parenchymal retention can distort a whole-kidney curve.¹
• Confirm the diuretic was delivered. Infiltration of the furosemide (or tracer) injection, or a mistimed dose, blunts the diuresis and mimics obstruction. Injecting through an established cannula rather than a fresh direct stick reduces infiltration risk.¹
• Match the protocol to the kidney. A markedly dilated, well-functioning system may favor an F − 15 approach so the diuresis is already maximal; a baseline-plus-furosemide protocol suits the standard case.
• Keep the camera and processing honest. Accurate quantitation presumes a uniform, well-tuned gamma camera and consistent processing. The upstream discipline is the same covered in gamma camera uniformity QC.

Read the half-time in context

Report the washout half-time together with the renogram curve shape, the differential function, the hydration and bladder conditions, and any technical caveats. A number without its context invites overcall. When function is too poor to generate diuresis, say so rather than reporting a misleadingly long half-time as "obstruction."²

Regulatory Considerations

Diuretic renography uses byproduct material and therefore falls under the NRC or Agreement State medical-use framework, even though the study itself is low-dose and routine. The governing structure is familiar from any nuclear medicine program:

• 10 CFR Part 35 — Medical Use of Byproduct Material governs authorized use of Tc-99m radiopharmaceuticals, the authorized user, dose measurement, and record-keeping.⁴
• 10 CFR Part 20 — Standards for Protection Against Radiation sets the occupational and public dose limits and the ALARA framework that shape administered-activity choices.⁵
• Radiopharmaceutical dosimetry. ICRP Publication 128 provides the organ and effective-dose coefficients used to estimate patient dose for Tc-99m MAG3, DTPA, and related agents at a given administered activity — the basis for keeping activity as low as reasonably achievable while preserving diagnostic count statistics.⁶
• Agreement States. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey license medical use under their own radiation-control programs (Florida under Chapter 64E-5), while Washington DC and Delaware are regulated directly by the NRC. Confirm which authority issues the license and which record-keeping and dose requirements apply.

The practice framework itself — administered activity, furosemide dosing, acquisition, and interpretation — follows the SNMMI Procedure Standard/EANM Practice Guideline for diuretic renal scintigraphy, which is the document a program should align its protocol and quality control against.¹ For the broader dosimetry context, see our guide to radiopharmaceutical dosimetry and ICRP 128.

Frequently Asked Questions (FAQs)

What is diuretic renography used for?

Diuretic renography distinguishes a dilated collecting system that is genuinely obstructed from one that is dilated but drains freely. It is most often used to evaluate suspected upper urinary tract obstruction, such as ureteropelvic junction obstruction, where anatomic imaging shows dilation but cannot tell whether urine flow is impeded.¹²

Why is furosemide (Lasix) given during the scan?

Furosemide produces a high rate of urine flow. In a non-obstructed system the increased flow flushes the radiopharmaceutical out of the collecting system quickly; in a truly obstructed system the activity stays trapped despite the diuresis. The response to the diuretic is what separates the two.¹

What washout half-time indicates obstruction?

There is general agreement that a washout half-time under about 10 minutes excludes obstruction. Longer half-times are more concerning — values over about 20 minutes are often interpreted as consistent with obstruction and 10 to 20 minutes as equivocal — but the half-time must always be read together with the renogram curve, the degree of function, and the hydration and technical conditions, because the threshold is not perfectly standardized.¹²

What radiopharmaceutical is used for diuretic renography?

Tc-99m MAG3 is the most common agent because it is cleared efficiently by tubular secretion and gives good images even when renal function is reduced. Tc-99m DTPA (glomerular filtration) and Tc-99m ethylenedicysteine are alternatives. A typical adult administered activity is in the range of about 37 to 185 MBq, with up to roughly 370 MBq when a good first-pass bolus is needed.¹

What causes a false-positive diuretic renogram?

Dehydration, a full bladder, poor renal function that blunts the diuretic response, an inadequate or mistimed furosemide dose, and a region of interest that includes a dilated pelvis can all slow apparent washout and mimic obstruction. Standardized hydration, bladder drainage, correct furosemide timing, and careful region-of-interest placement are the main defenses.¹²

How much radiation dose does the study involve?

Diuretic renography is a low-dose nuclear medicine study. The effective dose depends on the radiopharmaceutical and administered activity but is generally small; published radiopharmaceutical dosimetry such as ICRP Publication 128 provides the organ and effective-dose coefficients used to estimate it for a given activity.⁶

Key Takeaways

• Dilation is not obstruction. Diuretic renography converts an anatomic finding into a functional test by stressing the collecting system with furosemide.¹²
• Tc-99m MAG3 is the preferred agent because tubular secretion gives strong images even when function is reduced; DTPA and EC are alternatives.¹
• Furosemide timing is a named protocol (F + 20, F − 15, F = 0, and others); the standard adult dose is 0.5 mg/kg or 40 mg.¹
• The washout half-time is computed from the post-diuretic monoexponential: $T_{1/2}=0.693/k$. Under ~10 min excludes obstruction; over ~20 min suggests it; 10–20 min is equivocal.¹²
• Technique drives accuracy. Hydration, bladder management, correct furosemide delivery, and clean ROIs are the main defenses against false positives.¹²
• A half-time without context is dangerous — a poorly functioning kidney that cannot respond to furosemide can look obstructed when it is not.²

Conclusion

Diuretic renography is a small, elegant physiology experiment run inside a gamma camera: flood the system with urine and see whether the tracer leaves. When the hydration is right, the furosemide is delivered on a standardized schedule, the bladder is managed, and the washout half-time is computed from a clean collecting-system region, the study reliably separates the kidney that needs intervention from the one that does not. When those elements slip, the same number becomes a false positive. The physics is straightforward; the discipline is everything. A program that standardizes technique and holds its quantitation to a documented protocol gives its urologists and nephrologists a result they can act on with confidence.¹²

How DRPS Can Help

Diagnostic Radiation Physics Services (DRPS) supports nuclear medicine programs across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware with gamma camera quality control, quantitative processing review, protocol standardization against SNMMI/EANM guidance, and radiation safety documentation through our PET/CT and nuclear medicine physics and medical physicist consulting services.

A dependable diuretic renography program is built on reproducible technique and defensible quantitation — the same foundation that makes every functional nuclear medicine study worth acting on.

Related Resources

• Renal scintigraphy and split renal function
• Quantitative SPECT/CT calibration
• Gamma camera uniformity QC
• Radiopharmaceutical dosimetry and ICRP 128
• Tc-99m generator quality control
• PET/CT and nuclear medicine physics
• Medical physicist consulting

References

1. Taylor AT, Brandon DC, de Palma D, et al. SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0. Seminars in Nuclear Medicine. 2018;48(4):377-390. doi:10.1053/j.semnuclmed.2018.02.010. doi.org
2. Taylor AT. Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications. Journal of Nuclear Medicine. 2014;55(5):786-798. doi:10.2967/jnumed.113.133454. doi.org
3. O'Reilly PH. Standardization of the renogram technique for investigating the dilated upper urinary tract and assessing the results of surgery. BJU International. 2003;91(3):239-243. doi:10.1046/j.1464-410x.2003.04050.x. doi.org
4. U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. ecfr.gov
5. U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov
6. International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances. ICRP Publication 128. Annals of the ICRP. 2015;44(2 Suppl). icrp.org
7. Taylor AT. Radionuclides in nephrourology, Part 1: radiopharmaceuticals, quality control, and quantitative indices. Journal of Nuclear Medicine. 2014;55(4):608-615. doi:10.2967/jnumed.113.133447. doi.org
8. Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. Journal of Nuclear Medicine. 1996;37(11):1883-1890. PubMed